Pfizer Escapes Anti-Monopoly Ruling In Indonesia For Amlodipine
This article was originally published in PharmAsia News
Executive Summary
An Indonesian court reversed a year-old anti-monopoly ruling against Pfizer Inc. and four of its units, the first cartel case in the country involving the pharmaceutical industry